期刊文献+

糖尿病视网膜病变表观遗传修饰的作用研究进展 被引量:1

Epigenetic modifications in diabetic retinopathy
原文传递
导出
摘要 DNA甲基化、组蛋白转录后修饰、非编码RNA调节等表观遗传修饰是环境刺激引起的可逆、可遗传改变。高糖血症、氧化应激、糖基化终产物等导致糖尿病及其并发症发生发展的主要刺激因素均能导致视网膜血管内皮细胞、视网膜色素上皮细胞内异常基因表观遗传修饰。异常基因表观遗传修饰在糖尿病视网膜病变(DR)黄斑水肿、新生血管形成等病理过程发挥重要作用;引起的代谢记忆现象导致即便血糖控制,DR等糖尿病并发症仍将进一步进展。表观遗传改变还能代代相传,在家族性糖尿病形成中发挥重要作用。深入探讨表观遗传修饰对DR发生发展的影响可为DR预防治疗提供新的思路。 Epigenetic modifications such as DNA methylation, histone post-translational modifications, non-coding RNA are reversible, heritable alterations which are induced by environmental stimuli. Major risk factors of diabetes and diabetic complications including hyperglycemia, oxidative stress and advanced glycation end products, can lead to abnormal epigenetic modifications in retinal vascular endothelial cells and retinal pigment epithelium cells. Epigenetic mechanisms are involved in the pathogenesis of macular edema and neovascularization of diabetic retinopathy (DR), as well as diabetic metabolic memory. The heritable nature of epigenetic marks also plays a key role in familial diabetes mellitus. Further elucidation of epigenetic mechanisms in DR can open the way for the discovery of novel therapeutic targets to prevent DR progression.
作者 陈文文 常青
出处 《中华眼底病杂志》 CAS CSCD 北大核心 2016年第2期213-217,共5页 Chinese Journal of Ocular Fundus Diseases
基金 国家自然科学基金(81371041)
关键词 DIABETIC retinopathy/genetics EPIGENESIS GENETIC Review Diabetic retinopathy/genetics Epigenesis, genetic Review
  • 相关文献

参考文献68

  • 1Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT/EDIC Study 30-year follow-up[J/OL]. Diabetes Care, 2016 : E151990 [ 2016-02-09]. httpt//care, diabetesjournals, org/content/early/2016/01/29/dcl5- 1990. [published online ahead of print].
  • 2Aiello LP, DCCT/EDIC Research Group. Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study [J]. Diabetes Care, 2014, 37 ( 1), 17-23.
  • 3Ranjit Unnikrishnan I, Anjana RM, Mohan V. Importance of controlling diabetes early--the concept of metabolic memory, legacy effect and the case for early insulinisation [J]. J Assoc Physicians India, 2011,59 SupphS8-12.
  • 4Writing Team for the Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus [J]. JAMA, 2002,287 (19) ,2563-2569.
  • 5Perrone L, Matrone C, Singh LP. Epigenetic modifications and potential new treatment targets in diabetic retinopathy[J/OL]. J Ophthalmol,2014, 2014:789120 [2014-07-24]. https://www. researchgate, net/publication/264166836_Erratum_to_Epigenetic _Modifications _ and _ Potential _ New_ Treatment _ Targets _ in _ Diabetic_Retinopathy. DOh 10. 1155/2014/789120.
  • 6Reddy MA, Zhang E, Natarajan R. Epigenetic mechanisms in diabetic complications and metabolic memory [J]. Diabetologia, 2015,58(3) :443-455.
  • 7Egger G, Liang G, Aparicio A, et al. Epigenetics in human disease and prospects for epigenetic therapy [J]. Nature, 2004, 429(6990) :457-463.
  • 8Bird A. Perceptions of epigenetics [J]. Nature, 2007, 447 (7143) : 396-398.
  • 9Intine RV, Olsen AS, Sarras MJ. A zebrafish model of diabetes mellitus and metabolic memory [J/OL]. J Vis Exp, 2013(72): 50232 [ 2013-02-28 ]. http://www, jove. com/video/50232/a- zebrafish-model-of-diabetes-mellit us-and-metaboliz-memory. DOI 10. 3791/50232.
  • 10Reddy MA, Natarajan R. Epigenetic mechanisms in diabetic vascular complications [J]. Cardiovasc Res, 2011,90 (3) : 421- 429.

二级参考文献19

  • 1Chung HS, Hams A, Halter P J, Kagemann L, Roff EJ, Garzozi HJ ,et al. Regional differences in retinal vascular reactivity [J]. Invest Ophthalmol Vis Sci,1999,40( 10) :2448-2453.
  • 2Moore P, EI-sherbeny A, Roon P, Schoenlein PV, Ganapathy V, Smith SB. Apoptosis cell death in the mouse retinal ganglion cell layer is induced in vivo by the excitatory amino acid homocysteine[J]. EX] Eye Res ,2001,73 (1) :45-57.
  • 3Gray SG, Ekstrom TJ. The human histone deacetylase family [J]. Exp Cell Res ,2001 ,262( 2) :75-83.
  • 4Michishita E, Park JY, Bumeskis JM, Barrett JC ,Horikawa I. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins [J]. Mol Biol Cell, 2005, 16( 10) :4623-4635.
  • 5Escande C, Chini CC, Nin V, Dykhouse KM, Novak CM, Levine J ,et al. Deleted in breast cancer-I regulates SIRTI activity and contributes to high-fat diet-induced liver steatosis in mice [J] . J Clin Invest ,2010 ,120(2) :545-548.
  • 6Giannakou ME, Partridge L. The interaction between FOXO and SIRTI : tipping the balance towards survival [J]. Trends Cell Biol,2004,14(8) :408-412.
  • 7Picard F, Kurtev M, Chung N, Topark- Ngarm A, Senawong T, Machado De Oliveira, et al. Sirtl promotes fat mobilization in white adipocytes by repressing PPAR-gamma[J]. Nature ,2004, 429(6993) :771-776.
  • 8Revollo JR, Grimm AA, Imai S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells [J]. J Biol Chem , 2004 , 279 (49) :50754-50763.
  • 9Inoue Y,Iemura S,Natsume T,Miyazawa K,Imamura T. Suppression of p53 activity through the cooperative action of ski and histone deacetylase SIRTI [J] . J Biol Chem, 2011 ,286 ( 8 ) : 6311-6320.
  • 10Luo J,Nikolaev AY,Imai S,Chen D,Su F,Shiloh A,et al. Negative control of p53 by Sir-alpha promotes cell survival under stress[J]. Cell,2001 ,107(2) :137-148.

共引文献5

同被引文献4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部